| BRIEF COMMUNICATION |
|
| Ahead of Print |
|
|
Treatment options used in COVID-19 Disease: Steroids, anticoagulants, remdesivir and/or antibiotics – Which worked better or combo was the right choice?
Shital Patil1, Ganesh Narwade1, Gajanan Gondhali2
1 Department of Pulmonary Medicine, MIMSR Medical College, Latur, Maharashtra, India
2 Department of Internal Medicine, MIMSR Medical College, Latur, Maharashtra, India
Correspondence Address:
Shital Patil,
Department of Pulmonary Medicine, MIMSR Medical College, Latur, Maharashtra
India
 Source of Support: None, Conflict of Interest: None DOI: 10.4103/jascp.jascp_25_22
|
|
|
Coronavirus disease 2019 (COVID-19) is the first coronavirus-related global pandemic caused by a novel severe acute respiratory syndrome coronavirus-2, and rapid evolution of the pandemic has resulted in fast-track developments in antivirals, medical management, and vaccination for use to prevent morbidity and mortality. As of today, different institutional treatment protocols and respective national guidelines have been evolved worldwide with team of medical experts and recommended for combinations of antiviral, antibiotics, steroids, and anticoagulants with variable outcomes. Combination therapy has documented better outcome with a significant reduction in mortality and morbidity and considered frontline protocol during this pandemic.
|
|
|
|
|
|
|
Search Pubmed for